Automotive and Transportation Automotive and Transportation

Drugmakers Will Ask Trump to Pause Price Negotiations


Published on 2025-01-14 00:20:39 - MSN
  Print publication without navigation

  • Drugmaker Eli Lilly & Co. has asked the US government to pause its forward march with drug-price negotiations, potentially thwarting the Biden administration's plans to release a new list of drug targets before leaving office next week.

Eli Lilly has requested that the Biden administration pause its drug price negotiation program, arguing that the process lacks transparency and could hinder innovation in the pharmaceutical industry. The company expressed concerns that the negotiations, part of the Inflation Reduction Act, might not adequately consider the value of new medicines or the costs associated with their development. Lilly's CEO, David Ricks, emphasized the need for a more open dialogue with the government to ensure that the pricing strategy supports continued research and development while making drugs affordable. This request comes amidst ongoing debates about how best to balance drug affordability with the incentives for pharmaceutical innovation.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/politics/government/lilly-asks-biden-administration-to-pause-drug-price-negotiations/ar-BB1rnZ74 ]
Similar Automotive and Transportation Articles
[ Mon, Jan 13th ] - MSN
[ Fri, Dec 13th 2024 ] - AARP